Prediction: Lilly Will Trade at $1,200 by Year-End
Investors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
An overview of situations where market-cap weighted benchmarks are appropriate and practical tips for effective performance comparison.
28,411 articlesInvestors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Semiconductors led by the SMH and SOXX pulled back sharply, triggering fresh talk of a buyable dip. Famous tech inves...
ASML and Applied Materials ride an AI-capex wave, but their business models diverge. ASML benefits from EUV pricing p...
Chipotle and Microsoft have taken divergent paths in 2026. CMG rides restaurant-demand strength while MSFT grapples w...
Two physical silver ETFs track the LBMA price, but a fee gap and liquidity differences drive the decision on which to...
Nebius shares fell about 13% in afternoon trading as the neocloud trade shows renewed pressure on asset-light AI clou...
Aluminum equities trade higher as supply discipline tightens and demand from aerospace and packaging stays resilient....
A rally in Cava lifted the restaurant group, but Sweetgreen’s disappointing sales offer pulled markets back, undersco...
A fresh Goldman Sachs memo warns that risk premia have fallen to crisis-era levels, signaling a potential stock marke...
As tensions rise, Iran warns of $200 barrels even as the U.S. and IEA launch a massive emergency oil release. The mov...
A growth stock that surged to lofty heights last year has cooled in 2026, but big buyers keep stepping in as AI capac...
Today’s market shows a blend of volatility and opportunity. Planet Labs led a surge on strong earnings, while broader...